{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:29:52Z","timestamp":1762374592660},"reference-count":36,"publisher":"Elsevier BV","issue":"9085","license":[{"start":{"date-parts":[[1997,10,1]],"date-time":"1997-10-01T00:00:00Z","timestamp":875664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1997,10]]},"DOI":"10.1016\/s0140-6736(97)03495-8","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T13:37:16Z","timestamp":1027604236000},"page":"1136-1139","source":"Crossref","is-referenced-by-count":88,"title":["Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease"],"prefix":"10.1016","volume":"350","author":[{"given":"O","family":"Bandmann","sequence":"first","affiliation":[]},{"given":"J","family":"Vaughan","sequence":"additional","affiliation":[]},{"given":"P","family":"Holmans","sequence":"additional","affiliation":[]},{"given":"CD","family":"Marsden","sequence":"additional","affiliation":[]},{"given":"NW","family":"Wood","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(97)03495-8_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp.62.1.10","article-title":"Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON collaborative study","volume":"62","author":"Rijk","year":"1997","journal-title":"J Neural Neurosurg Psychiatry"},{"key":"10.1016\/S0140-6736(97)03495-8_bib2","series-title":"Disorders of movement","first-page":"33","article-title":"The pathology of parkinsonian disorders","author":"Gibb","year":"1989"},{"key":"10.1016\/S0140-6736(97)03495-8_bib3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"Mapping of a gene for Parkinson's disease to chromosome 4q21\u201323","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"key":"10.1016\/S0140-6736(97)03495-8_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/jnnp.62.4.305","article-title":"Genes and parkins onism","volume":"62","author":"Wood","year":"1997","journal-title":"J N enrol Neurosurg Psychiatry"},{"key":"10.1016\/S0140-6736(97)03495-8_bib5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1212\/WNL.46.5.1275","article-title":"Possible environmental, occupational and other ecological factors for Parkinson's disease: a case control study in Germany","volume":"46","author":"Seidler","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(97)03495-8_bib6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0140-6736(94)92347-7","article-title":"Oxidative damage in neurodegenerative disease","volume":"344","author":"Jenner","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(97)03495-8_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/mds.870090202","article-title":"Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal","volume":"9","author":"Schapira","year":"1994","journal-title":"Mov Disord"},{"key":"10.1016\/S0140-6736(97)03495-8_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.45.6.1041","article-title":"Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?","volume":"45","author":"Morens","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(97)03495-8_bib9","first-page":"827","article-title":"Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology","volume":"52","author":"Lin","year":"1993","journal-title":"Ani J Hum Genet"},{"key":"10.1016\/S0140-6736(97)03495-8_bib10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0140-6736(92)90537-D","article-title":"Mutant debrisoquine hydroxylation genes in Parkinson's disease","volume":"339","author":"Armstrong","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(97)03495-8_bib11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/0140-6736(92)91196-F","article-title":"Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease","volume":"339","author":"Smith","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(97)03495-8_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.jbchem.a124164","article-title":"A novel cytochrome P450IID6 mutant gene associated wtih Parkinson's disease","volume":"114","author":"Tsuneoka","year":"1993","journal-title":"J Biochem"},{"key":"10.1016\/S0140-6736(97)03495-8_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ana.410400319","article-title":"Genetic variability of the CYP2D6 gene is not a risk factor for sporadic Parkinson's disease","volume":"40","author":"Diederich","year":"1996","journal-title":"Ann Neural"},{"key":"10.1016\/S0140-6736(97)03495-8_bib14","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1046\/j.1471-4159.1995.65062561.x","article-title":"Ethanol induces cytochrome P4502E1 and induces oxidative stress in astrocytes","volume":"65","author":"Montoliu","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/S0140-6736(97)03495-8_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(86)92471-2","article-title":"Lipid peroxidation as cause of nigral cell death in Parkinson's disease","volume":"ii","author":"Dexter","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(97)03495-8_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson's disease and other neuro degenerative disorders affecting the basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(97)03495-8_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/oxfordjournals.jbchem.a123619","article-title":"Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene","volume":"110","author":"Hayashi","year":"1991","journal-title":"J Biochem"},{"key":"10.1016\/S0140-6736(97)03495-8_bib18","first-page":"797","article-title":"NAD(P)H: quinone oxidoreductase gene expression in human colon carcinoma cells: characterisation of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity","volume":"52","author":"Traver","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(97)03495-8_bib19","series-title":"Glutathione conjugation: mechanisms and biological significance","author":"Sies","year":"1988"},{"key":"10.1016\/S0140-6736(97)03495-8_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S0140-6736(97)03495-8_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.410350107","article-title":"Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease","volume":"35","author":"Dexter","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(97)03495-8_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s004150050082","article-title":"Mitochondrial DNA polymorphisms in pathologically proven Parkinson's disease","volume":"244","author":"Bandmann","year":"1997","journal-title":"J Neurol"},{"key":"10.1016\/S0140-6736(97)03495-8_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/mds.870060303","article-title":"A clinical and genetic study of familial Parkinson's disease","volume":"6","author":"Maraganore","year":"1991","journal-title":"Mov Disord"},{"key":"10.1016\/S0140-6736(97)03495-8_bib24","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/BF00205091","article-title":"A polymorphic cfo I site in exon 6 of the human cytochrome P450IID6 gene detected by the polymerase chain reaction","volume":"91","author":"Armstrong","year":"1993","journal-title":"Hum Genet"},{"key":"10.1016\/S0140-6736(97)03495-8_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/oxfordjournals.jbchem.a124526","article-title":"Different regulation and expression of the human CYP2E1 gene due to the Rsal polymorphism in the 5' flanking region","volume":"116","author":"Watanabe","year":"1994","journal-title":"J Biochem"},{"key":"10.1016\/S0140-6736(97)03495-8_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00008571-199508000-00003","article-title":"Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer and smoking","volume":"5","author":"Rosvold","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0140-6736(97)03495-8_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00008571-199604000-00005","article-title":"Simultaneous characterisation of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks","volume":"6","author":"Chen","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S0140-6736(97)03495-8_bib28","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/carcin\/14.8.1689","article-title":"Genotype\/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans","volume":"14","author":"Bell","year":"1993","journal-title":"Carcino genesis"},{"key":"10.1016\/S0140-6736(97)03495-8_bib29","first-page":"541","article-title":"Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease","volume":"45","author":"Payami","year":"1989","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0140-6736(97)03495-8_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.36.2.250","article-title":"MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease","volume":"36","author":"Snyder","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(97)03495-8_bib31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00558506","article-title":"Acetylator polymorphism in Parkinson's disease","volume":"37","author":"Ladero","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/S0140-6736(97)03495-8_bib32","first-page":"807","article-title":"Xenobiotic metabolism in idiopathic Parkinson's disease in Nigerian Africans","volume":"70","author":"Igbokwe","year":"1993","journal-title":"East Afr Med J"},{"key":"10.1016\/S0140-6736(97)03495-8_bib33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3109\/00498259409043298","article-title":"D-penicillamine metabolism in neuro degenerative disease: an in vivo\/in vitro sulphydryl methylation study","volume":"24","author":"Peters","year":"1994","journal-title":"Xenobiotica"},{"key":"10.1016\/S0140-6736(97)03495-8_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/hmg\/4.2.231","article-title":"Slow N-acetylation genotype is a subsequent factor in occupational and smoking related bladder cancer","volume":"4","author":"Risch","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S0140-6736(97)03495-8_bib35","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1073\/pnas.88.12.5237","article-title":"Molecular mechanism of slow acetylation of drugs and carcinogens in humans","volume":"88","author":"Blum","year":"1991","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/S0140-6736(97)03495-8_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/369154a0","article-title":"Genetically based N-acetyltransferase metabolic polymorphism and low level environmental exposure to carcinogens","volume":"369","author":"Vineis","year":"1994","journal-title":"Nature"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673697034958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673697034958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T07:53:11Z","timestamp":1556524391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673697034958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":36,"journal-issue":{"issue":"9085","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["S0140673697034958"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(97)03495-8","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}